Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KMB vs MRNA✓SelectedUSD · MRNAKMB vs MRNA performance historyLatest closeAs of-2.87%11/17
Stock and ETF performance explorer

KMB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+26.3%
MRNA return
+840.0%
Excess return
-813.7%
Maximum drawdown
-34.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.9%-3.9%+1.1%-2.8%
7D-2.4%-17.6%+15.2%-2.0%
30D+2.4%-5.1%+7.6%+2.5%
3M+1.4%+220.8%-219.4%-2.7%
6M+15.7%+321.7%-306.0%+10.0%
YTD+11.3%+601.3%-589.9%+4.0%
1Y+9.7%+735.2%-725.5%+1.8%
3Y+1.0%+170.5%-169.6%-4.4%
5Y-2.2%-14.6%+12.4%-5.4%
All+26.3%+840.0%-813.7%+1.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling